PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+19.19%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$783M
AUM Growth
+$783M
(+6.7%)
Cap. Flow
-$26.8M
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
34.67%
Holding
106
New
16
Increased
38
Reduced
39
Closed
12
Top Buys
| 1 |
Teleflex
TFX
|
$23.8M |
| 2 |
Keros Therapeutics
KROS
|
$13M |
| 3 |
Stryker
SYK
|
$10.1M |
| 4 |
Viridian Therapeutics
VRDN
|
$9.67M |
| 5 |
Arcus Biosciences
RCUS
|
$9.33M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$17M |
| 2 |
Elevance Health
ELV
|
$15M |
| 3 |
Humana
HUM
|
$11.2M |
| 4 |
Tenet Healthcare
THC
|
$9.17M |
| 5 |
Boston Scientific
BSX
|
$8.75M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Elanco Animal Health
ELAN
$8.62B
| $1.88M | 0.24% |
127,812
+1,770
| +1% | +$26K |
|
77
Ironwood Pharmaceuticals
IRWD
$201M
| $1.88M | 0.24% |
455,477
-420,791
| -48% | -$1.73M |
|
|
NARI
78
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $1.83M | 0.23% |
44,301
-151,266
| -77% | -$6.24M |
|
79
NewAmsterdam Pharma
NAMS
$2.8B
| $1.75M | 0.22% |
105,334
-30,042
| -22% | -$499K |
|
80
Pulmonx
LUNG
$67.6M
| $1.71M | 0.22% |
+206,444
| New | +$1.71M |
|
81
Eton Pharmaceutcials
ETON
$468M
| $1.56M | 0.2% |
260,226
+7,029
| +3% | +$42.2K |
|
82
Esperion Therapeutics
ESPR
$490M
| $1.49M | 0.19% |
903,140
-241,506
| -21% | -$398K |
|
|
CLYM
83
Climb Bio, Inc. Common Stock
CLYM
$151M
| $1.42M | 0.18% |
+278,775
| New | +$1.42M |
|
84
Alpha Teknova
TKNO
$227M
| $1.21M | 0.16% |
251,026
-45,626
| -15% | -$221K |
|
|
AKYA
85
DELISTED
Akoya BioSciences
AKYA
| $1.02M | 0.13% |
376,131
+595
| +0.2% | +$1.62K |
|
86
Ardelyx
ARDX
$1.57B
| $875K | 0.11% |
126,940
-23,252
| -15% | -$160K |
|
87
Entera Bio
ENTX
$92.7M
| $781K | 0.1% |
411,076
+9,558
| +2% | +$18.2K |
|
88
Reviva Pharmaceuticals
RVPH
$31.3M
| $738K | 0.09% |
512,202
+7,602
| +2% | +$10.9K |
|
89
X4 Pharmaceuticals
XFOR
$70M
| $548K | 0.07% |
27,291
+404
| +2% | +$8.11K |
|
|
EDAP
90
EDAP TMS
EDAP
$103M
| $395K | 0.05% |
+154,832
| New | +$395K |
|
91
VYNE Therapeutics
VYNE
$8.09M
| $382K | 0.05% |
202,973
-142,233
| -41% | -$267K |
|
92
Xeris Biopharma Holdings
XERS
$1.27B
| $292K | 0.04% |
102,393
+1,563
| +2% | +$4.46K |
|
93
InspireMD
NSPR
$101M
| $279K | 0.04% |
+104,081
| New | +$279K |
|
94
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-200,000
| Closed | -$8.31M |
|
95
Cencora
COR
$57.2B
| – | – |
-38,014
| Closed | -$8.56M |
|
|
96
Elevance Health
ELV
$72.4B
| – | – |
-27,751
| Closed | -$15M |
|
97
Fortrea Holdings
FTRE
$971M
| – | – |
-152,769
| Closed | -$3.57M |
|
98
Haemonetics
HAE
$2.57B
| – | – |
-76,079
| Closed | -$6.29M |
|
|
99
Humana
HUM
$37.5B
| – | – |
-30,037
| Closed | -$11.2M |
|
100
Ionis Pharmaceuticals
IONS
$9.64B
| – | – |
-161,705
| Closed | -$7.71M |
|